{
    "id": 14029,
    "fullName": "KDR A1065T",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "KDR (VEGFR2) A1065T lies within the protein kinase domain of the Kdr (Vegfr2) protein (UniProt.org). A1065T is predicted to confer a gain of function to the Kdr (Vegfr2) protein, as demonstrated by constitutive tyrosine autophosphorylation (PMID: 19723655).",
            "references": [
                {
                    "id": 217,
                    "pubMedId": 19723655,
                    "title": "KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19723655"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3791,
        "geneSymbol": "KDR",
        "terms": [
            "KDR",
            "CD309",
            "FLK1",
            "VEGFR",
            "VEGFR2"
        ]
    },
    "variant": "A1065T",
    "createDate": "11/18/2015",
    "updateDate": "09/13/2018",
    "referenceTranscriptCoordinates": {
        "id": 102160,
        "transcript": "NM_002253",
        "gDna": "chr4:g.55089802C>T",
        "cDna": "c.3193G>A",
        "protein": "p.A1065T",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1572,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells expressing KDR A1065T were sensitive to Sutent (sunitinib) in culture (PMID: 19723655).",
            "molecularProfile": {
                "id": 14289,
                "profileName": "KDR A1065T"
            },
            "therapy": {
                "id": 930,
                "therapyName": "Sunitinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 217,
                    "pubMedId": 19723655,
                    "title": "KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19723655"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 14289,
            "profileName": "KDR A1065T",
            "profileTreatmentApproaches": [
                {
                    "id": 7082,
                    "name": "VEGFR2 Inhibitor",
                    "profileName": "KDR A1065T"
                },
                {
                    "id": 7081,
                    "name": "VEGFR Inhibitor (Pan)",
                    "profileName": "KDR A1065T"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 102160,
            "transcript": "NM_002253",
            "gDna": "chr4:g.55089802C>T",
            "cDna": "c.3193G>A",
            "protein": "p.A1065T",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}